Shandong Xinhua Pharmaceutical.
HK$5.89
3
-HK$0.01-0.17% 今天
統計
當日最高
5.98
當日最低
5.86
52週最高
8.05
52週最低
4.8
成交量
1,430,000
平均成交量
2,497,292
市值
-
市盈率
-
股息收益率
45.85%
股息
2.7
即將到來
股息
45.85%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
N/A
1年增長率
25.04%
收益
30Oct預期
預期每股收益
N/A
實際每股收益
N/A
人們還關注
此列表基於在 Stock Events 上關注 719.HK 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
BeiGene
BGNE
市值21.34B
Zoomlion Heavy Industry Science and Technology
ZLIOY
市值7.14B
Sinopharm Group
SHTDY
市值7.28B
Santen Pharmaceutical.
SNPHY
市值4.38B
Johnson & Johnson
JNJ
市值399.26B
Pfizer
PFE
市值164.39B
Novartis
NVS
市值244.75B
GSK
GSK
市值89.55B
Merck
MRK
市值300.25B
關於
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Show more...
首席執行官
Mr. Tongqing He
員工
7064
國家
CN
ISIN
CNE100000411